Search Within

Christopher G Azzoli

  1. "2005"
Formats
  1. Meeting Abstract (6)
  2. Journal Article (3)
Groups
  1. Department of Medicine (8)
  2. Solid Tumor Oncology Division (8)
  3. Thoracic Oncology (8)
  4. Nursing (4)
  5. Advanced Practice Providers (2)
  6. GSK Faculty (2)

More Groups

People
  1. Mark Kris (8)
  2. Jorge Gomez (6)
  3. Barbara Pizzo (4)
  4. Lee Krug (4)
  5. Naiyer Rizvi (4)
  6. Vincent Miller (4)

More People

Years
  1. 2005 (9)
Publications
  1. Journal of Clinical Oncology (4)
  2. Cancer (2)
  3. Lung Cancer (2)
  4. Nature Clinical Practice Oncology (1)
Publishers
  1. American Society of Clinical Oncology (4)
  2. Elsevier Ireland Ltd. (2)
  3. Wiley Blackwell (2)
  4. Nature Publishing Group (1)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I/II trial of gefitinib and RAD001 (everolimus) in patients (pts) with advanced non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Milton, D. T.; Kris, M. G.; Azzoli, C. G.; Gomez, J. E.; Heelan, R.; Krug, L. M.; Pao, W.; Pizzo, B.; Rizvi, N. A.; Miller, V. A.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Phase 1 study of 10-propargyl-10-deazaaminopterin (PDX, pralatrexate) plus docetaxel in patients with advanced Non-Small Cell Lung Cancer (NSCLC)
    Meeting Abstract

    Gomez, J.; Azzoli, C.; Krug, L.; Ginsberg, M.; Henry, R.; Tyson, L.; Pizzo, B.; Dunne, M.; Kris, M.; Sirotnak, F.
    Lung Cancer (2005)

    Fulltext@MSK | Save
  • A phase I dose escalation trial of pulsatile high dose gefitinib and docetaxel in patients with an advanced solid tumor
    Meeting Abstract

    Fury, M. G.; Kris, M.; Solit, D.; Pfister, D. G.; Azzoli, C. G.; Henry, R.; Su, Y. B.; Rizvi, N.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Measurements of total DNA and methylated tumor suppressor genes in the plasma of patients with small cell lung cancer (SCLC)
    Meeting Abstract

    Chen, L. C.; Krug, L. M.; Azzoli, C. G.; Park, S. J.; Gomez, J.; Danenberg, K.; Danenberg, P.; Kris, M. G.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Biomarkers for small cell lung cancer (SCLC): DNA methylation and GD2 synthase transcript levels
    Meeting Abstract

    Chen, L.; Krug, L.; Azzoli, C.; Cheung, I.; Park, S.; Danenberg, P.; Danenberg, K.; Cheung, N.; Kris, M.
    Lung Cancer (2005)

    Fulltext@MSK | Save
  • Measurements of total DNA and methylated tumor suppressor genes in the plasma of patients with metastatic non-small cell lung cancer (NSCLC) before, and after chemotherapy, as potential biomarkers for response to treatment
    Meeting Abstract

    Azzoli, C. G.; Park, S.; Gomez, J.; Krug, L.; Miller, V.; Rizvi, N.; Ben-Porat, L.; Danenberg, K.; Danenberg, P.; Kris, M.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Randomized phase II study of weekly docetaxel plus trastuzumab versus weekly paclitaxel plus trastuzumab in patients with previously untreated advanced nonsmall cell lung carcinoma
    Journal Article

    Krug, L. M.; Miller, V. A.; Patel, J.; Crapanzano, J.; Azzoli, C. G.; Gomez, J.; Kris, M. G.; Heelan, R. T.; Pizzo, B.; Tyson, L.; more...
    Cancer (2005)

    Fulltext@MSK | Save
  • Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein: A phase II clinical trial
    Journal Article

    Krug, L. M.; Crapanzano, J. P.; Azzoli, C. G.; Miller, V. A.; Rizvi, N.; Gomez, J.; Kris, M. G.; Pizzo, B.; Tyson, L.; Dunne, M.; more...
    Cancer (2005)

    Fulltext@MSK | Save
  • Can adjuvant chemotherapy improve survival in patients with early-stage, resected non-small-cell lung cancer?
    Journal Article

    Azzoli, C. G.
    Nature Clinical Practice Oncology (2005)

    Fulltext@MSK | Save